Christopher Dean

THE RECEPTOR FOR EGF AND ITS LIGANDS - EXPRESSION, PROGNOSTIC VALUE AND TARGET FOR THERAPY IN CANCER (REVIEW)

Helmout Modjtahedi, Christopher Dean · International Journal of Oncology · 1994 · 138 citations

Growth Factor Receptors, Signaling Pathway, Medicine +12

Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor

Tahereh Kamalati, Helen E. Jolin, Philip J. Mitchell et al. · Journal of Biological Chemistry · 1996 · 124 citations · Full text

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

Helmout Modjtahedi, Tamas Hickish, Margery Nicolson et al. · British Journal of Cancer · 1996 · 102 citations · Full text

Malignant Disease, Medicine, Immunology +10

Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.

Sue Eccles, William Court, Gary Box et al. · PubMed · 1994 · 80 citations

Mda Mb 361, Breast Oncology, Pathology +18

An evaluation of four CT–MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients

Christopher Dean, Jonathan Sykes, Rachel Cooper et al. · British Journal of Radiology · 2011 · 72 citations · Full text